BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 1347231)

  • 1. Comparison of the train-of-four fade profiles produced by vecuronium and atracurium.
    Fletcher JE; Sebel PS; Mick SA; Van Duys J; Ryan K
    Br J Anaesth; 1992 Feb; 68(2):207-8. PubMed ID: 1347231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the onset time, duration of action, and fade characteristics of atracurium and vecuronium.
    Haines M
    AANA J; 1993 Dec; 61(6):592-6. PubMed ID: 7903505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Train-of-four fade during onset of neuromuscular block with nondepolarising neuromuscular blocking agents.
    Gibson FM; Mirakhur RK
    Acta Anaesthesiol Scand; 1989 Apr; 33(3):204-6. PubMed ID: 2567104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nondepolarizing neuromuscular blocking drugs and train-of-four fade.
    McCoy EP; Connolly FM; Mirakhur RK; Loan PB; Paxton LD
    Can J Anaesth; 1995 Mar; 42(3):213-6. PubMed ID: 7743572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical neuromuscular pharmacology of cisatracurium versus vecuronium during outpatient anesthesia.
    Stevens JB; Walker SC; Fontenot JP
    Anesth Analg; 1997 Dec; 85(6):1278-83. PubMed ID: 9390594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Onset and duration of clinical relaxation of atracurium and vecuronium in patients on chronic nifedipine therapy.
    Bell PF; Mirakhur RK; Elliott P
    Eur J Anaesthesiol; 1989 Sep; 6(5):343-6. PubMed ID: 2571501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromuscular blocking effects and train-of-four fade with cisatracurium: comparison with other nondepolarising relaxants.
    Carroll MT; Mirakhur RK; Lowry DW; McCourt KC; Kerr C
    Anaesthesia; 1998 Dec; 53(12):1169-73. PubMed ID: 10193219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison between vecuronium and atracurium in myasthenia gravis.
    Chan KH; Yang MW; Huang MH; Hseu SS; Chang CC; Lee TY; Lin CY
    Acta Anaesthesiol Scand; 1993 Oct; 37(7):679-82. PubMed ID: 7902637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extending a pipecuronium neuromuscular block. Increments of atracurium or vecuronium as an alternative to pipecuronium.
    Roberts SP; Ramsay TM; Healy TE; Wilson A; Pollard BJ
    Anaesthesia; 1993 Mar; 48(3):196-9. PubMed ID: 8096370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative neuromuscular blockade: a comparison between atracurium, vecuronium, and pancuronium.
    Bevan DR; Smith CE; Donati F
    Anesthesiology; 1988 Aug; 69(2):272-6. PubMed ID: 2900612
    [No Abstract]   [Full Text] [Related]  

  • 11. Interaction of vecuronium and atracurium during halothane anaesthesia in children.
    Sloan MH; Bissonnette B; Lerman J
    Anaesthesia; 1998 Jan; 53(1):36-40. PubMed ID: 9505740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potency and maintenance requirement of atracurium and vecuronium given alone or together.
    Rautoma P; Erkola O; Meretoja OA
    Acta Anaesthesiol Scand; 1995 Feb; 39(2):220-3. PubMed ID: 7793191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of isoflurane and sevoflurane on the magnitude and time course of neuromuscular block produced by vecuronium, pancuronium and atracurium.
    Vanlinthout LE; Booij LH; van Egmond J; Robertson EN
    Br J Anaesth; 1996 Mar; 76(3):389-95. PubMed ID: 8785139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is recovery of neuromuscular transmission complete after the use of neostigmine to antagonize block produced by rocuronium, vecuronium, atracurium and pancuronium?
    Baurain MJ; Hoton F; D'Hollander AA; Cantraine FR
    Br J Anaesth; 1996 Oct; 77(4):496-9. PubMed ID: 8942335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous recovery of residual neuromuscular blockade after atracurium or vecuronium during isoflurane anaesthesia.
    Erkola O; Karhunen U; Sandelin-Hellqvist E
    Acta Anaesthesiol Scand; 1989 May; 33(4):290-4. PubMed ID: 2566251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients.
    Prielipp RC; Coursin DB; Scuderi PE; Bowton DL; Ford SR; Cardenas VJ; Vender J; Howard D; Casale EJ; Murray MJ
    Anesth Analg; 1995 Jul; 81(1):3-12. PubMed ID: 7598277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Profile of the effect of succinylcholine after pre-curarization with atracurium, vecuronium or pancuronium].
    Ebeling BJ; Keienburg T; Hausmann D; Apffelstaedt C
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Jun; 31(5):304-8. PubMed ID: 8767244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of integrated evoked EMG between the hypothenar and facial muscle groups following atracurium and vecuronium administration.
    Sharpe MD; Moote CA; Lam AM; Manninen PH
    Can J Anaesth; 1991 Apr; 38(3):318-23. PubMed ID: 1674676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atracurium and vecuronium interaction with gentamicin and tobramycin.
    Dupuis JY; Martin R; Tétrault JP
    Can J Anaesth; 1989 Jul; 36(4):407-11. PubMed ID: 2569365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the neuromuscular and cardiovascular effects of vecuronium, atracurium and mivacurium in sheep.
    Clutton RE; Glasby MA
    Res Vet Sci; 1998; 64(3):233-7. PubMed ID: 9690609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.